Prab at 13:40, 12 July 2026

2026-07-12T13:40:55Z

← Older revision		Revision as of 13:40, 12 July 2026
Line 67:		Line 67:
	[[File:W8MD-Team.jpg\|thumb\|right\|350px\|[[W8MD Weight Loss, Sleep and MedSpa]] provides physician-supervised GLP-1/GIP medication evaluation, dose escalation guidance, nutrition support, and sleep medicine care.]]		[[File:W8MD-Team.jpg\|thumb\|right\|350px\|[[W8MD Weight Loss, Sleep and MedSpa]] provides physician-supervised GLP-1/GIP medication evaluation, dose escalation guidance, nutrition support, and sleep medicine care.]]
	[[File:Woman-losing-weight.jpeg\|thumb\|right\|350px\|Successful tirzepatide treatment depends on dose, nutrition, protein planning, activity, sleep, side-effect management, and long-term maintenance.]]		[[File:Woman-losing-weight.jpeg\|thumb\|right\|350px\|Successful tirzepatide treatment depends on dose, nutrition, protein planning, activity, sleep, side-effect management, and long-term maintenance.]]
	~~[[File:Body mass index chart.svg\|thumb\|right\|300px\|[[Body mass index]] is one tool used to determine eligibility for anti-obesity medications.]]~~
	~~[[File:Obesity-waist circumference.svg\|thumb\|right\|300px\|[[Waist circumference]], [[central obesity]], and [[visceral fat]] are important markers of metabolic risk.]]~~

	==Overview==		==Overview==
Line 114:		Line 112:

	==Standard tirzepatide dose escalation schedule==		==Standard tirzepatide dose escalation schedule==
			[[File:Body mass index chart.svg\|thumb\|right\|300px\|[[Body mass index]] is one tool used to determine eligibility for anti-obesity medications.]]

	The official Zepbound prescribing information recommends starting at 2.5 mg once weekly for 4 weeks, then increasing to 5 mg once weekly. If additional response is needed, the dosage may be increased in 2.5 mg increments after at least 4 weeks on the current dose. The maximum dose is 15 mg once weekly.<ref name="ZepboundLabel">{{cite web\|url=https://pi.lilly.com/us/zepbound-uspi.pdf\|title=Zepbound prescribing information\|publisher=Eli Lilly and Company\|accessdate=2026-07-12}}</ref>		The official Zepbound prescribing information recommends starting at 2.5 mg once weekly for 4 weeks, then increasing to 5 mg once weekly. If additional response is needed, the dosage may be increased in 2.5 mg increments after at least 4 weeks on the current dose. The maximum dose is 15 mg once weekly.<ref name="ZepboundLabel">{{cite web\|url=https://pi.lilly.com/us/zepbound-uspi.pdf\|title=Zepbound prescribing information\|publisher=Eli Lilly and Company\|accessdate=2026-07-12}}</ref>

Prab: Created page with "{{Short description|Tirzepatide dose escalation, starting doses, titration, side effects, maintenance, microdosing, and W8MD medical weight loss care}} {{DISPLAYTITLE:Tirzepatide dose escalation}} NOTOC {{Infobox drug | drug_name = Tirzepatide dose escalation | image = 250px | caption = Tirzepatide dose escalation should be individualized and medically supervised to balance weight loss, tolerability, side effects, and long-..."

2026-07-12T13:35:34Z

Created page with "{{Short description|Tirzepatide dose escalation, starting doses, titration, side effects, maintenance, microdosing, and W8MD medical weight loss care}} {{DISPLAYTITLE:Tirzepatide dose escalation}} __NOTOC__ {{Infobox drug | drug_name = Tirzepatide dose escalation | image = 250px | caption = Tirzepatide dose escalation should be individualized and medically supervised to balance weight loss, tolerability, side effects, and long-..."

Show changes

Tirzepatide dose escalation - Revision history

Prab at 13:40, 12 July 2026